Clayton Financial Group’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-675
Closed -$81.2K 387
2026
Q1
$81.2K Hold
675
0.04% 114
2025
Q4
$71.1K Buy
+675
New +$63.4K 0.04% 126
2025
Q2
Sell
-5,718
Closed -$513K 80
2025
Q1
$513K Sell
5,718
-76
-1% -$7.1K 0.19% 64
2024
Q4
$576K Sell
5,794
-34
-0.6% -$3.5K 0.21% 64
2024
Q3
$662K Buy
5,828
+471
+9% +$56K 0.25% 57
2024
Q2
$707K Hold
5,357
0.31% 52
2024
Q1
$707K Buy
+5,357
New +$660K 0.32% 50

Other funds holding MRK

Clayton Financial Group's MRK Position: Q2 2026 in Review

Clayton Financial Group sold out of Merck (MRK) in Q2 2026, closing a stake of 675 shares — an estimated $81.2K sold.

Clayton Financial Group first reported a position in MRK in Q1 2024 and held it in 7 quarters. The position peaked at $707K in Q2 2024. 1,299 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Clayton Financial Group reported no remaining Merck position as of Q2 2026 after selling out during the quarter.
  • Clayton Financial Group sold 675 Merck shares in Q2 2026, an estimated $81.2K.
  • Clayton Financial Group first reported a position in Merck in Q1 2024 and held it in 7 quarters.
  • Clayton Financial Group's Merck position peaked at $707K in Q2 2024.
  • 1,299 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Clayton Financial Group's 13F filing for Q2 2026, filed 20 Jul 2026.